Juan P. Brito Campana, M.B.B.S.

Location

Contact

SUMMARY

Juan P. Brito Campana, M.B.B.S., is an endocrinologist, health care researcher, medical director of the Mayo Clinic Shared Decision Making National Resource Center and principal investigator in the Knowledge and Evaluation Research Unit (KER). Thyroid cancer is the most common cancer in young adults, and the fastest growing cancer in older Americans. Dr. Brito uses the tools of meta-analysis, large database analysis and shared decision-making to examine multiple dimensions of health care quality for patients with thyroid cancer. He is also interested in the evidence-based development of clinical practice guidelines and clinical decision-making for diagnostic tests.

Focus areas

• Epidemiology and large database analysis. Dr. Brito focuses on understanding trends and patterns of care for patients with thyroid nodules and thyroid cancer. He currently works with several collaborators in the U.S. and overseas using OptumLabs, national cancer databases and the Rochester Epidemiology Project.
• Evidence-based medicine and knowledge synthesis. Dr. Brito works in collaboration with Mayo Clinic's Evidence-Based Practice Research Program to conduct systematic reviews and meta-analysis on different thyroid-related topics. By collaborating with other researchers, he seeks to improve the development and implementation of clinical practice guidelines.
• Patient centered care. Dr. Brito and his collaborators in the KER unit have focused on research to improve patient outcomes. Particularly, he works on interventions that promote patient engagement into decision-making and decrease wasteful and low-value care for patients with thyroid cancer and thyroid nodules.

Significance to patient care

Dr. Brito aims to improve the lives of patients with thyroid cancer by improving the care they receive. Dr. Brito's hope is to understand the complexity of thyroid cancer and thyroid nodule care and to develop and test patient-centered interventions to decrease overdiagnosis and overtreatment for these patients.